NFE2L2 and neoplasm: As commented for 4-HNE, NF-κB, and Nrf2, the use of “high-dose antioxidants” during chemotherapy to prevent toxicity is also controversial, because of the potential protective effect on tumor cells and prognostic impairment [85,86].